Amer is currently the Managing Director of GxP Compliance and Training Partners (GCTP) founded to help pharmaceutical companies & academic institutions worldwide to achieve compliance with GCP, GVP, GCLP, GDP and GLP.
A clinical pharmacologist by education, he is a senior executive with 28 years’ experience within pre-clinical, clinical R&D and pharmacovigilance (PV) operations helping biotech and pharmaceutical companies worldwide to achieve compliance with GxPs (Good Laboratory Practice (GLP), Good Clinical Practice (GCP), Good Clinical Laboratory Practice (GCLP), Good Vigilance Practice (GVP) and Good Distribution Practice (GDP)) Quality Assurance (QA).
Amer enjoys imparting his experiences through training provision and has, for over 25 years, been delivering training on GxP QA, clinical development/operations and Pharmacovigilance, as well as being an invited speaker at over 130 international congresses and as writer, published 2 reference books, The Pharmaceutical Medicine Dictionary and The Dictionary of Pharmacovigilance and other publications. Earlier in his career, he was Assistant Editor for 11 medical journals and was the first invited Course Director for The Pharmacovigilance Auditing Course at the RQA.
Amer has over 21 years’ experience of directing and hosting Inspection Readiness Programs (Mock Inspections and Pre- / Post-Mock Inspection-Training).
His other previous positions include: Vice President GxP Quality Assurance, Compliance & Training at Karyopharm Therapeutics Inc. USA, Global Director, Head of Quality Assurance at Merck Serono, Switzerland, Global Head of GxP Quality Assurance at Arpida Ag., Switzerland, Senior International Clinical Quality Assurance Audit Manager at Novartis Headquarters, Switzerland and he was the first Pharmacovigilance Compliance Officer of the MHRA where he conducted the first GCP-GVP inspection in the EU.